Immune History and Influenza Vaccine Effectiveness
暂无分享,去创建一个
[1] Timothy B. Stockwell,et al. Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012–2013 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] A. Oberg,et al. Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers , 2015, Human vaccines & immunotherapeutics.
[3] M. Lipsitch,et al. Quantifying biases in test-negative studies of vaccine effectiveness , 2017, bioRxiv.
[4] Patrick C. Wilson,et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.
[5] Francisco Y Cai,et al. Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a whole-cell vaccine , 2018, PLoS Comput. Biol..
[6] M E Halloran,et al. Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.
[7] M. Weatherall,et al. Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[8] A. Monto,et al. Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018 , 2018, MMWR. Morbidity and mortality weekly report.
[9] C. A. Russell,et al. Antibody landscapes after influenza virus infection or vaccination , 2014, Science.
[10] S. Hensley,et al. Immune history and influenza virus susceptibility. , 2017, Current opinion in virology.
[11] Laura C. Rosella,et al. Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada , 2010, PLoS medicine.
[12] Michael Haber,et al. The case test-negative design for studies of the effectiveness of influenza vaccine. , 2013, Vaccine.
[13] D. Skowronski,et al. Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015 , 2017, The Journal of infectious diseases.
[14] A S Perelson,et al. Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] Seth J. Zost,et al. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains , 2017, Proceedings of the National Academy of Sciences.
[16] James O. Lloyd-Smith,et al. Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting , 2016, Science.
[17] Cecile Viboud,et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.
[18] C. Bauch,et al. Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis , 2013, BMC Medicine.
[19] A. Monto,et al. Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. , 2016, The Journal of infectious diseases.
[20] Gleider Hernández,et al. Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022 , 2022, Vaccine.
[21] J. Belmont,et al. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. , 2013, The Journal of infectious diseases.
[22] T. Jefferson,et al. Vaccines for preventing influenza in healthy adults. , 2014, The Cochrane database of systematic reviews.
[23] M. Halloran,et al. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. , 1995, International journal of epidemiology.
[24] A. Monto,et al. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. , 2011, The Journal of infectious diseases.
[25] Raphael Gottardo,et al. Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses , 2017, Science Immunology.
[26] Jill M Ferdinands,et al. RE: "INVITED COMMENTARY: BEWARE THE TEST-NEGATIVE DESIGN". , 2017, American journal of epidemiology.
[27] A. Costello,et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study , 2015 .
[28] D. Shay,et al. Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] Alicia M. Fry,et al. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings , 2016, International journal of epidemiology.
[30] A. Monto,et al. Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated. , 2016, The Journal of infectious diseases.
[31] A. Monto,et al. Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017 , 2017, MMWR. Morbidity and mortality weekly report.
[32] X. Wan,et al. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] P. Small,et al. The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection. , 2017, Vaccine.
[34] A. Monto,et al. 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] A. Monto,et al. Interim estimates of 2017–18 seasonal influenza vaccine effectiveness — United States, February 2018 , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[36] Cécile Viboud,et al. Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.
[37] P G Smith,et al. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. , 1984, International journal of epidemiology.
[38] D. Cummings,et al. Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data , 2015, PLoS biology.
[39] Gavin J. D. Smith,et al. Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China , 2012, PLoS pathogens.
[40] Diane J Post,et al. A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases , 2018, The Journal of infectious diseases.
[41] B. Cowling,et al. The test-negative design for estimating influenza vaccination effectiveness , 2017, Online Journal of Public Health Informatics.
[42] Jin Hyang Kim,et al. Strategies to alleviate original antigenic sin responses to influenza viruses , 2012, Proceedings of the National Academy of Sciences.
[43] M. Hudgens,et al. Increased risk of influenza among vaccinated adults who are obese , 2017, International Journal of Obesity.
[44] M. Lipsitch,et al. Measurement of vaccine direct effects under the test-negative design , 2018 .
[45] D. Skowronski,et al. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[46] Tom Jefferson,et al. Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.
[47] A. Monto,et al. Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] B. Cowling,et al. Influenza vaccine effectiveness in the community and the household. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] M. Gomes,et al. Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence , 2016, Vaccine.
[50] A. Monto,et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] D. Vaughn,et al. Seeking Help: B Cells Adapting to Flu Variability , 2014, Science Translational Medicine.
[52] S. Hensley,et al. Antibodies with ‘Original Antigenic Sin’ Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses , 2016, PLoS pathogens.
[53] D. Skowronski,et al. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada , 2017, The Journal of infectious diseases.
[54] J. Myśliwska,et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. , 2003, Vaccine.
[55] J. Yewdell,et al. MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines , 2011, Science Translational Medicine.
[56] S. Cobey,et al. Vaccination and the evolution of seasonal influenza , 2017 .
[57] S. Klein,et al. Sex-based biology and the rational design of influenza vaccination strategies. , 2014, The Journal of infectious diseases.
[58] D. Skowronski,et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. , 2014, The Journal of infectious diseases.
[59] Martin Lam,et al. A Rejoinder , 1990, The Knowledge Engineering Review.
[60] R B Couch,et al. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.
[61] K. Ainslie,et al. On the bias of estimates of influenza vaccine effectiveness from test-negative studies. , 2017, Vaccine.
[62] C. Broome,et al. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. , 1980, New England Journal of Medicine.
[63] D. Mak,et al. Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[64] K. Ariyoshi,et al. Dose-Dependent Negative Effects of Prior Multiple Vaccinations Against Influenza A and Influenza B Among Schoolchildren: A Study of Kamigoto Island in Japan During the 2011–2012, 2012–2013, and 2013–2014 Influenza Seasons , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] A. Monto,et al. Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States , 2018, The Journal of infectious diseases.
[66] Matthew S. Miller,et al. Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic , 2018, mBio.
[67] Francisco Y. Cai,et al. Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a vaccine , 2018, bioRxiv.
[68] Nicholas S. Kelley,et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. , 2016, The Lancet. Infectious diseases.
[69] T. Jefferson,et al. Vaccines for preventing influenza in healthy children. , 2012, The Cochrane database of systematic reviews.
[70] Patrick C. Wilson,et al. Immune history profoundly affects broadly protective B cell responses to influenza , 2015, Science Translational Medicine.
[71] Matthew S. Miller,et al. “Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy , 2018, Vaccines.
[72] K. Ainslie,et al. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination , 2017, BMC Infectious Diseases.
[73] A. Monto,et al. Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. , 2016, The Journal of infectious diseases.
[74] B. Cowling,et al. Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis , 2017, American journal of epidemiology.
[75] Marc Lipsitch,et al. Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies. , 2016, International journal of epidemiology.
[76] C. Broome,et al. Pneumococcal Disease after Pneumococcal Vaccination , 1980 .
[77] E. Belongia,et al. Effect of Statin Use on Influenza Vaccine Effectiveness , 2016, The Journal of infectious diseases.
[78] V. Pitzer,et al. Waxing Understanding of Waning Immunity. , 2018, The Journal of infectious diseases.
[79] David J. Topham,et al. Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies , 2018, Cell.
[80] T. Friedrich,et al. Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[81] J. Plotkin,et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses , 2013, The Journal of experimental medicine.
[82] The beneficial effects of vaccination on the evolution of seasonal influenza , 2020 .
[83] R. Karron,et al. The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder. , 2018, Vaccine.
[84] Richard K. Zimmerman,et al. Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.
[85] Edward A Belongia,et al. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence , 2017, Expert review of vaccines.
[86] T. Jefferson,et al. Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.
[87] B. Cowling,et al. Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. , 2010, Clinical Infectious Diseases.
[88] R. Greenlee,et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. , 2009, The Journal of infectious diseases.
[89] J. R. Turner. Efficacy , 2020, Encyclopedia of Behavioral Medicine.
[90] P. Palese,et al. Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans , 2016, mBio.
[91] Marc Lipsitch,et al. Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials. , 2012, AIDS.
[92] M. Eichelberger,et al. The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014–2015 Influenza Vaccine , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[93] B. Cowling,et al. The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis , 2017, BMC Medicine.
[94] J K McLaughlin,et al. Selection of controls in case-control studies. II. Types of controls. , 1992, American journal of epidemiology.
[95] F. M. Davenport,et al. A SEROLOGIC RECAPITULATION OF PAST EXPERIENCES WITH INFLUENZA A; ANTIBODY RESPONSE TO MONOVALENT VACCINE , 1956, The Journal of experimental medicine.
[96] Eric J Tchetgen Tchetgen,et al. Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness. , 2016, American journal of epidemiology.
[97] Florian Krammer,et al. Neutralizing Antibodies Against Previously Encountered Influenza Virus Strains Increase over Time: A Longitudinal Analysis , 2013, Science Translational Medicine.
[98] Michael G Hudgens,et al. Invited Commentary: Beware the Test-Negative Design. , 2016, American journal of epidemiology.
[99] A. Wilder-Smith,et al. Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies , 2018, The Journal of infectious diseases.
[100] T. Kepler,et al. Memory B Cells that Cross‐React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires , 2018, Immunity.
[101] Tom Jefferson,et al. واکسنها برای پیشگیری از وقوع آنفلوآنزا در کودکان سالم , 2018 .
[102] S. Omer,et al. Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness. , 2016, The Journal of infectious diseases.
[103] Mark M. Davis,et al. Cytomegalovirus infection enhances the immune response to influenza , 2015, Science Translational Medicine.
[104] D. Skowronski,et al. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. , 2015, The Journal of infectious diseases.
[105] J. Bloom,et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season , 2014, Proceedings of the National Academy of Sciences.
[106] W. Ndifon. A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants , 2015, Journal of The Royal Society Interface.